Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
66 participants
OBSERVATIONAL
2023-05-04
2023-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
• What are the experiences and perceptions of end-of-life communication in Chinese terminally ill patients, families and healthcare providers? Participants will be invited to either semi-structured in-depth interviews or focus group discussions to share their thoughts.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Culturally Specific End-of-life Communication Skills Training
NCT05888480
Intervention Study on Life Review Among Advanced Cancer Patients in Fuzhou, China
NCT00951262
An Interactive Advance Care Planning Intervention to Facilitate a Good Death for Cancer Patients
NCT01912846
Expressive Helping for Chinese-Speaking Cancer Patients and Survivors
NCT03945734
Empathetic Communication Facilitation Program for Early Initiation of End-of-life Discussions
NCT05045040
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Design and subjects: This study is a qualitative study. Eligible patients, family caregivers and healthcare providers will be recruited in two hospitals. Purposive sampling methods will be adopted. Semi-structured in-depth interviews with patients and family caregivers will be conducted respectively. Focus group discussions will be arranged with healthcare providers, allowing them to discuss end-of-life communication and generate group interactions and creative thinking.
Data analysis: The data analysis will be an iterative, cyclic and self-reflective process. Using inductive thematic analysis, common themes and categories will be determined through inductive reasoning and constant comparison.
Expected results: The study will fill the gap of no empirical evidence on end-of-life communication strategies from a Chinese perspective and enrich the knowledge about end-of-life communication.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Interviewees: terminally ill patients, families and healthcare providers of such patients
Not Application as this is a qualitative study
Not Application as this is a qualitative study
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Not Application as this is a qualitative study
Not Application as this is a qualitative study
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Be aged older than 18 years
* Have a defined incurable life-limiting illness with a likely life expectancy of fewer than 12 months (National Institute for Health and Care Excellence, 2021), according to the consultation with the patient's physician
* Have been informed of disease diagnosis and treatment
* Be able to speak Mandarin and express clearly
* Be able to provide informed consent
Family caregivers:
* Be aged older than 18 years
* One of the terminally ill patient's primary family caregivers who are familiar with patient's situation, which is defined as lived with or visited patients at least twice a week in the past month
* Have been informed of patient's disease diagnosis and treatment
* Be able to speak Mandarin
* Be able to provide informed consent
Healthcare providers:
* Be nurses, physicians or other healthcare professionals
* Be experienced in providing treatment or care to patients with advanced, life-limiting illnesses (whose likely life expectancies of fewer than 12 months) and family caregivers of such patients for at least five years (Koh et al., 2016)
* Consent to participate in the study
Exclusion Criteria
* Severe auditory impairment
* Cognitive impairment
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Hong Kong Polytechnic University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr Joyce Chung
Assistant Professor, School of Nursing
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joyce Chung, PhD
Role: PRINCIPAL_INVESTIGATOR
The Hong Kong Polytechnic University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Zhejiang Cancer Hospital
Hangzhou, Zhejiang, China
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Chen W, Chung JOK, Lam KKW, Molassiotis A. Patients', families' and healthcare providers' perspectives on end-of-life communication in Chinese hospital settings: A qualitative study protocol. PLoS One. 2023 Dec 27;18(12):e0296342. doi: 10.1371/journal.pone.0296342. eCollection 2023.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HSEARS20221217002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.